|
1
|
Carey VJ, Bishop L, Laranjo N, Harshfield
BJ, Kwiat C and Sacks FM: Contribution of high plasma triglycerides
and low high-density lipoprotein cholesterol to residual risk of
coronary heart disease after establishment of low-density
lipoprotein cholesterol control. Am J Cardiol. 106:757–763. 2010.
View Article : Google Scholar
|
|
2
|
Maász A, Kisfali P, Horvatovich K, et al:
Apolipoprotein A5 T-1131C variant confers risk for metabolic
syndrome. Pathol Oncol Res. 13:243–247. 2007.PubMed/NCBI
|
|
3
|
Evans D, Aberle J and Beil FU:
Resequencing the apolipoprotein A5 (APOA5) gene in patients with
various forms of hypertriglyceridemia. Atherosclerosis.
219:715–720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peden JF and Farrall M: Thirty-five common
variants for coronary artery disease: the fruits of much
collaborative labour. Hum Mol Genet. 20:R198–R205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pennacchio LA, Olivier M, Hubacek JA,
Cohen JC, Cox DR, Fruchart JC, Krauss RM and Rubin EM: An
apolipoprotein influencing triglycerides in humans and mice
revealed by comparative sequencing. Science. 294:169–173. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martinelli N, Trabetti E, Bassi A, Girelli
D, Friso S, Pizzolo F, Sandri M, Malerba G, Pignatti PF, Corrocher
R and Olivieri O: The -1131 T>C and S19W APOA5 gene
polymorphisms are associated with high levels of triglycerides and
apolipoprotein C-III, but not with coronary artery disease: an
angiographic study. Atherosclerosis. 191:409–417. 2007.
|
|
7
|
Szalai C, Keszei M, Duba J, Prohászka Z,
Kozma GT, Császár A, Balogh S, Almássy Z, Fust G and Czinner A:
Polymorphism in the promoter region of the apolipoprotein A5 gene
is associated with an increased susceptibility for coronary artery
disease. Atherosclerosis. 173:109–114. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu H, Zhang S, Lin J, et al: Association
between DNA variant sites in the apolipoprotein A5 gene and
coronary heart disease in Chinese. Metabolism. 54:568–572. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Triglyceride Coronary Disease Genetics
Consortium and Emerging Risk Factors Collaboration. Sarwar N,
Sandhu MS, Ricketts SL, et al: Triglyceride-mediated pathways and
coronary disease: collaborative analysis of 101 studies. Lancet.
375:1634–1639. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu Y, Xue L and Zhao CY: Study on
polymorphism in the apolipoprotein A5 gene in patients with
premature coronary heart disease. Beijing Da Xue Xue Bao.
39:576–580. 2007.(In Chinese).
|
|
11
|
Li X, Yao C, Song M, Ma J, Ning H and Hu
B: The relationship between the polymorphism of apolipoprotein A5
gene 56C>G and the level of serum triglyceride. Ningxia Yi Xue
Za Zhi. 9:643–645. 2006.(In Chinese).
|
|
12
|
Lai CQ, Tai ES, Tan CE, Cutter J, Chew SK,
Zhu YP, Adiconis X and Ordovas JM: The APOA5 locus is a strong
determinant of plasma triglyceride concentrations across ethnic
groups in Singapore. J Lipid Res. 44:2365–2373. 2003. View Article : Google Scholar
|
|
13
|
Kao JT, Wen HC, Chien KL, Hsu HC and Lin
SW: A novel genetic variant in the apolipoprotein A5 gene is
associated with hypertriglyceridemia. Hum Mol Genet. 12:2533–2539.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang Y, Sun P, Guo D, Ferro A, Ji Y, Chen
Q and Fan L: A genetic variant c.553G>T in the apolipoprotein A5
gene is associated with an increased risk of coronary artery
disease and altered triglyceride levels in a Chinese population.
Atherosclerosis. 185:433–437. 2006.PubMed/NCBI
|
|
15
|
Prochaska CL, Picheth G, Anghebem-Oliveira
MI, Costantini CO, de Souza EM, Pedrosa FO and Scartezini M: The
polymorphisms -1131T>C and the S19W of the APOA5 gene are not
associated with coronary artery disease in a Brazilian population.
Clin Chem Lab Med. 48:419–422. 2010.
|
|
16
|
Maász A, Kisfali P, Szolnoki Z, Hadarits F
and Melegh B: Apolipoprotein A5 gene C56G variant confers risk for
the development of large-vessel associated ischemic stroke. J
Neurol. 255:649–654. 2008.PubMed/NCBI
|
|
17
|
No authors listed. Nomenclature and
criteria for diagnosis of ischemic heart disease. Report of the
Joint International Society and Federation of Cardiology/World
Health Organization task force on standardization of clinical
nomenclature. Circulation. 59:607–609. 1979. View Article : Google Scholar
|
|
18
|
Nikus KC: Chapter 4: Coranory angiography.
Multimodal Imaging: Principles and Clinical Applications: Section
I: Current methods and their applications for cardiovascular
multimodal imaging. Pahlm O and Wagner GS: McGraw-Hill Medical; New
York, NY: pp. 752011
|
|
19
|
Higgs ZC, Macafee DA, Braithwaite BD and
Maxwell-Armstrong CA: The Seldinger technique: 50 years on. Lancet.
366:1407–1409. 2005.PubMed/NCBI
|
|
20
|
Gabriel S, Ziaugra L and Tabbaa D: SNP
genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc
Hum Genet. (Suppl 60): 2.12.1–2.12.18. 2009.
|
|
21
|
Excoffier L and Lischer HE: Arlequin suite
ver 3.5: a new series of programs to perform population genetics
analyses under Linux and Windows. Mol Ecol Resour. 10:564–567.
2010. View Article : Google Scholar
|
|
22
|
Sham PC and Curtis D: Monte Carlo tests
for associations between disease and alleles at highly polymorphic
loci. Ann Hum Genet. 59(Pt 1): 97–105. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dupont WD and Plummer WD Jr: Power and
sample size calculations. A review and computer program. Control
Clin Trials. 11:116–128. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aberle J, Evans D, Beil FU and Seedorf U:
A polymorphism in the apolipoprotein A5 gene is associated with
weight loss after short-term diet. Clin Genet. 68:152–154. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu HK, Wang CT, Zhang SZ, et al:
Association of APOA5 gene single nucleotide polymorphism with
levels of lipids and coronary heart disease in Chinese. Zhonghua Yi
Xue Yi Chuan Xue Za Zhi. 21:335–338. 2004.(In Chinese).
|
|
26
|
Yuan S, Ma YT, Xie X, Yang YN, Fu ZY, Ma
X, Li XM, Xiang Y, Liu F and Chen BD: Association of apolipoprotein
A5 gene polymorphism with coronary heart disease in Uygur
population of Xinjiang. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
28:73–77. 2011.(In Chinese).
|
|
27
|
Hubacek JA, Wang WW, Skodová Z, Adámková
V, Vráblík M, Horínek A, Stulc T, Ceska R and Talmud PJ: APOA5
Ala315>Val, identified in patients with severe
hypertriglyceridemia, is a common mutation with no major effects on
plasma lipid levels. Clin Chem Lab Med. 46:773–777. 2008.PubMed/NCBI
|
|
28
|
Eichenbaum-Voline S, Olivier M, Jones EL,
et al: Linkage and association between distinct variants of the
APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
Arterioscler Thromb Vasc Biol. 24:167–174. 2004. View Article : Google Scholar
|
|
29
|
Yuan S, Ma YT, Xie X, Yang YN, Fu ZY, Ma
X, Li XM, Liu F and Chen BD: Association between apolipoprotein A5
gene polymorphism and coronary heart disease in the Han population
from Xinjiang. Zhonghua Liu Xing Bing Xue Za Zhi. 32:51–54.
2011.(In Chinese).
|
|
30
|
Song KH, Yu SG, Cha S and Kim JY:
Association of the Apolipoprotein A5 gene -1131T>C polymorphism
with serum lipids in Korean subjects: impact of Sasang
constitution. Evid Based Complement Alternat Med.
2012:5983942012.
|
|
31
|
Ramakrishnan L, Sachdev HS, Sharma M, et
al: Relationship of APOA5, PPARγ and HL gene variants with serial
changes in childhood body mass index and coronary artery disease
risk factors in young adulthood. Lipids Health Dis. 10:682011.
|
|
32
|
Yan SK, Cheng XQ, Song YH, Xiao XH, Bi N
and Chen BS: Apolipoprotein A5 gene polymorphism -1131T→C:
association with plasma lipids and type 2 diabetes mellitus with
coronary heart disease in Chinese. Clin Chem Lab Med. 43:607–612.
2005.
|
|
33
|
Havasi V, Szolnoki Z, Talián G, et al:
Apolipoprotein A5 gene promoter region T-1131C polymorphism
associates with elevated circulating triglyceride levels and
confers susceptibility for development of ischemic stroke. J Mol
Neurosci. 29:177–183. 2006. View Article : Google Scholar
|
|
34
|
Maasz A, Kisfali P, Jaromi L, Horvatovich
K, Szolnoki Z, Csongei V, Safrany E, Sipeky C, Hadarits F and
Melegh B: Apolipoprotein A5 gene IVS3+G476A allelic variant confers
susceptibility for development of ischemic stroke. Circ J.
72:1065–1070. 2008.
|
|
35
|
Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY,
Choi JR, Lee SH, Shin DJ, Ordovas JM and Lee JH: The apolipoprotein
A5 -1131T>C promoter polymorphism in Koreans: association with
plasma APOA5 and serum triglyceride concentrations, LDL particle
size and coronary artery disease. Clin Chim Acta. 402:83–87.
2009.
|
|
36
|
Ruiz-Narváez EA, Yang Y, Nakanishi Y,
Kirchdorfer J and Campos H: APOC3/A5 haplotypes, lipid levels, and
risk of myocardial infarction in the Central Valley of Costa Rica.
J Lipid Res. 46:2605–2613. 2005.PubMed/NCBI
|
|
37
|
Hubacek JA, Skodová Z, Adámková V, Lánská
V and Poledne R: The influence of APOAV polymorphisms (T-1131>C
and S19>W) on plasma triglyceride levels and risk of myocardial
infarction. Clin Genet. 65:126–130. 2004.
|
|
38
|
Dallongeville J, Cottel D, Montaye M,
Codron V, Amouyel P and Helbecque N: Impact of APOA5/A4/C3 genetic
polymorphisms on lipid variables and cardiovascular disease risk in
French men. Int J Cardiol. 106:152–156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dorfmeister B, Zeng WW, Dichlberger A, et
al: Effects of six APOA5 variants, identified in patients with
severe hypertriglyceridemia, on in vitro lipoprotein lipase
activity and receptor binding. Arterioscler Thromb Vasc Biol.
28:1866–1871. 2008. View Article : Google Scholar
|
|
40
|
Johansen CT, Kathiresan S and Hegele RA:
Genetic determinants of plasma triglycerides. J Lipid Res.
52:189–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lim S, Park YM, Sakuma I and Koh KK: How
to control residual cardiovascular risk despite statin treatment:
Focusing on HDL-cholesterol. Int J Cardiol. 166:8–14. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hokanson JE and Austin MA: Plasma
triglyceride level is a risk factor for cardiovascular disease
independent of high-density lipoprotein cholesterol level: a
meta-analysis of population-based prospective studies. J Cardiovasc
Risk. 3:213–219. 1996. View Article : Google Scholar
|
|
43
|
Merkel M and Heeren J: Give me A5 for
lipoprotein hydrolysis! J Clin Invest. 115:2694–2696.
2005.PubMed/NCBI
|
|
44
|
Li G, Wang JY, Yan S, Zhang LJ, Xue H,
Zeng WW, Wu G and Chen BS: The relationship between the
polymorphism of apolipoprotein A5 gene 56C→G and the levels of
serum triglyceride. Zhonggua Dong Mai Ying Hua Za Zhi. 5:574–576.
2004.(In Chinese).
|
